01—Abstract
Summary
Summary of the 10-Q filed August 1, 2025. Cited figures are marked; the original filing is the authoritative source.
Omega Healthcare Investors, Inc. (Parent, a Maryland corporation, with its consolidated subsidiaries referred to as "Omega" or the "Company") reported its quarterly results for the period ended June 30, 2025 in this Form 10-Q.
For the three months ended June 30, 2025, total revenues were $282.5 milliona versus $252.7 million a year earlier, and net income available to common stockholders was $136.6 million, or $0.46 per diluted share, compared with $113.9 million, or $0.45 per diluted share, in the prior-year quarter. For the six months ended June 30, 2025, net income available to common stockholders was $245.6 million, or $0.79 per diluted share. Rental income for the six months rose to $471.4 million from $421.2 million, and total assets reached $10.55 billion at June 30, 2025.
The Company expanded its portfolio during the period, acquiring 63 facilities for $560.4 millionb in the six months ended June 30, 2025, including a 45-facility acquisition in the U.K. and Jersey for $344.2 million. It sold 34 facilities for $183.0 million in net cash proceeds and issued $600 million of 5.200% Senior Notes due 2030 in June 2025. Common shares outstanding rose to 293.1 million at June 30, 2025, and the Company paid $383.8 million in dividends during the six months.
Cash and cash equivalents stood at $734.2 millionc at quarter end. Credit quality remained a concern. Maplewood is on a cash basis and short-paid rent, and its $320 million revolver is on non-accrual with no interest income recognized in the period.
LaVie's plan of reorganization took effect June 1, 2025, and Genesis Healthcare filed for Chapter 11 in July 2025, after the period end, with the Company committing up to $8.0 milliond to a $30.0 million DIP financing. Twenty-two operators were on a cash basis of revenue recognition, representing 17.5% of total revenues for the six months ended June 30, 2025.
02—Key points
Key Highlights
- Net income available to common stockholders of $136.6 million ($0.46 per diluted share) for Q2 2025, up from $113.9 million in Q2 2024; six-month figure of $245.6 million.
- Total revenues rose to $282.5 million for Q2 2025 from $252.7 million, driven by rental income of $239.2 million and interest income of $43.0 million.
- Acquired 63 facilities for $560.4 million in the six months ended June 30, 2025, including a 45-facility U.K. and Jersey acquisition for $344.2 million at an initial cash yield of 10.0%.
- Sold 34 facilities for $183.0 million in net cash proceeds in the six months, recognizing a net gain of $33.0 million.
- Issued $600 million of 5.200% Senior Notes due 2030 on June 20, 2025; $400 million of 4.50% notes matured in January 2025 and were repaid with cash.
- Maplewood's $320 million revolver is on non-accrual, and the operator short-paid rent; 22 operators (17.5% of six-month revenues) are on a cash basis of revenue recognition.
- Genesis Healthcare filed for Chapter 11 in July 2025, and the Company agreed to provide up to $8.0 million of a $30.0 million DIP financing; the 2025 Term Loan maturity was extended to August 2026.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ2 FY2025filed August 1, 2025Financial Statements
Q2 FY2025 against Q2 FY2024
| Line item | Q2 FY2025Q2 FY2024 | Change |
|---|---|---|
| Revenue | $282.51M$252.75M | +11.8% |
| Operating Expenses | $171.95M$149.89M | +14.7% |
| Operating Income | $281.24M— | — |
| Interest Expense | $52.90M$53.97M | −2.0% |
| Net Income | $136.60M$113.86M | +20.0% |
| EPS (Basic) | $0.46$0.46 | 0.0% |
| EPS (Diluted) | $0.46$0.45 | +2.2% |
| Shares Outstanding (Basic) | 291.19M249.37M | +16.8% |
| Shares Outstanding (Diluted) | 303.25M261.53M | +15.9% |
05—Questions
Frequently Asked Questions
How did Omega's earnings and revenue trend in the second quarter of 2025?
Total revenues were $282.5 million for the three months ended June 30, 2025, compared with $252.7 million a year earlier. Net income available to common stockholders was $136.6 million, or $0.46 per diluted share, versus $113.9 million, or $0.45 per diluted share, in the prior-year quarter. Gain on assets sold of $22.9 million and interest income of $43.0 million contributed to results.
What are the main credit risks in the portfolio?
Maplewood's $320 million revolving credit facility is on non-accrual status, with $263.6 million of amortized cost, and the operator failed to pay cash interest. Maplewood also short-paid contractual rent. Genesis filed for Chapter 11 in July 2025, and LaVie's plan of reorganization became effective June 1, 2025. The filing notes that if the proposed Maplewood transition is not completed, the Company may incur a substantial loss up to the amortized cost of the loan.
How much debt does Omega carry, and what are its upcoming maturities?
Total secured and unsecured borrowings, net, were $5.00 billion at June 30, 2025, representing 49.2% of total capitalization, with a weighted average annual interest rate of 4.6%. The next senior note maturity is $600 million of 5.250% notes due January 2026. The $251.6 million GBP-denominated 2026 mortgage loan matures in August 2026, and the $428.5 million 2025 Term Loan was extended to August 8, 2026. The $1.45 billion Revolving Credit Facility, with no borrowings outstanding, matures October 30, 2025 unless extended.
How is Omega funding its acquisitions and dividends?
The Company raised $517.9 million from common stock issuance in the six months ended June 30, 2025, including ATM Program proceeds of $272.3 million and DRCSPP proceeds of $250.2 million. It issued $600 million of 2030 Senior Notes in June 2025. Cash and cash equivalents were $734.2 million at June 30, 2025, and $548.6 million of potential ATM issuances remained. Dividends paid totaled $383.8 million for the six months, and the Board declared a $0.67 per share dividend on July 25, 2025.
06—Continue